An observational study in Sepsis, sponsored by Oslo University Hospital. Completed at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-03.
Sponsored by Oslo University Hospital · Observational
Does sepsis response team in the emergency department increase the portion of sepsis patient who receive adequate treatment within one hour?
Does sepsis response team in the emergency department increase the portion of sepsis patient who receive adequate treatment within one hour? The time from the patients arrive at the emergency department to an adequate antibiotic is given, before and after introduction of a sepsis response team, was registered.
1,899 studies on the registry are indexed under Sepsis; 462 are open to participants now.
This study's enrollment of 245 is above the median of 160 across 931 observational studies indexed under Sepsis.
Browse Sepsis studies →Oslo University Hospital is the lead sponsor of 810 studies on the registry; 148 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult patients with suspected sepsis in emergency department
Exclusion Criteria:
Time from arrival at the Emergency Department to antibiotic is administered, before introduction of sepsis response team in the Emergency Department.
Time from arrival at the Emergency Department to antibiotic is administered, with sepsis response team in the Emergency Department.
Other: Sepsis rapid response team
Patients with suspected sepsis is managed by a sepsis rapid response team in a structured manner.
Time from arrival the emergency department to antibiotic is given.
Time from arrival the emergency department to antibiotic is given.
Time frame: 6 months
Plan to share: No
This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oslo University Hospital